Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell Division Cycle 25C (CDC25C) is a dual specificity phosphatase that plays a critical role in regulating the G2/M transition of the cell cycle. It activates cyclin B-bound CDK1 by dephosphorylation, triggering entry into mitosis. CDC25C is involved in DNA damage repair and its dysregulation is implicated in cancer development, making it a potential therapeutic target.
Dephosphorylates cyclin B-bound CDK1, activating its kinase activity and triggering entry into mitosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell Division Cycle 25 Homolog C.